Characterizing the exposure-response relationship of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma

• Main Authors: Jamie N. Connarn (Author), Han Witjes (Author), Marielle van Zutphen‐van Geffen (Author), Rik deGreef (Author), Timothy B. Campbell (Author), Kristen Hege (Author), Simon Zhou (Author), Manisha Lamba (Author)
• Formato: Libro
• Publicado: Wiley, 2023-11-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Abstract Idecabtagene vicleucel (ide‐cel; bb2121) is a B‐cell maturation antigen-directed chimeric antigen receptor (CAR) T cell therapy approved for treatment of patients with heavily pretreated relapsed and refractory multiple myeloma. This analysis evaluated exposure-response (ER) relationships o...